Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
Sensus Healthcare Inc (NASDAQ: SRTS) closed the day trading at $3.81 down -0.52% from the previous closing price of $3.83. In other words, the price has decreased by -$0.52 from its previous closing price. On the day, 0.7 million shares were traded. SRTS stock price reached its highest trading level at $3.9309 during the session, while it also had its lowest trading level at $3.7.
Ratios:
For a better understanding of SRTS, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 8.23 and its Current Ratio is at 11.76. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.01.
Alliance Global Partners Upgraded its Neutral to Buy on August 10, 2020, whereas the target price for the stock was revised from $2.40 to $4.25.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Sep 14 ’23 when Sardano Joseph C bought 10,000 shares for $2.88 per share. The transaction valued at 28,773 led to the insider holds 1,175,293 shares of the business.
Sardano Michael bought 1,000 shares of SRTS for $2,990 on Aug 28 ’23. The PRESIDENT AND GENERAL COUNSEL now owns 58,774 shares after completing the transaction at $2.99 per share. On Aug 08 ’23, another insider, Sardano Joseph C, who serves as the CHIEF EXECUTIVE OFFICER of the company, bought 10,000 shares for $3.86 each. As a result, the insider paid 38,574 and bolstered with 1,165,293 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SRTS now has a Market Capitalization of 62458852 and an Enterprise Value of 49350160. As of this moment, Sensus’s Price-to-Earnings (P/E) ratio for their current fiscal year is 128.72, and their Forward P/E ratio for the next fiscal year is 21.17. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.56 while its Price-to-Book (P/B) ratio in mrq is 1.28. Its current Enterprise Value per Revenue stands at 2.022 whereas that against EBITDA is -461.216.
Stock Price History:
Over the past 52 weeks, SRTS has reached a high of $5.38, while it has fallen to a 52-week low of $1.79. The 50-Day Moving Average of the stock is 4.34%, while the 200-Day Moving Average is calculated to be 24.94%.
Shares Statistics:
Over the past 3-months, SRTS traded about 153.72K shares per day on average, while over the past 10 days, SRTS traded about 123910 shares per day. A total of 16.37M shares are outstanding, with a floating share count of 12.90M. Insiders hold about 21.33% of the company’s shares, while institutions hold 15.68% stake in the company. Shares short for SRTS as of 1713139200 were 33382 with a Short Ratio of 0.22, compared to 1710460800 on 65796. Therefore, it implies a Short% of Shares Outstanding of 33382 and a Short% of Float of 0.22999999999999998.
